Skip to content

Clinical trials

Phase 3 Epilepsy trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 3 Country / region: Russia Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20044
20054
20063
20076
20084
20104
20114
20123
20133
20143
20153
20161
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Pharma9
GlaxoSmithKline7
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.5
UCB BIOSCIENCES, Inc.5
Eisai Inc.3
Eisai Limited2
Marinus Pharmaceuticals2
UCB BIOSCIENCES GmbH2
Upsher-Smith Laboratories2
Bial - Portela C S.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy43
Seizures16
Epilepsies, Partial9
Epilepsy, Complex Partial1
Epilepsy, Tonic-Clonic1

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.